Park Ha Biological Technology (BYAH) Receivables - Other (2023 - 2026)

Park Ha Biological Technology has reported Receivables - Other for 4 years, with the latest figure at $769.0 in Q2 2026.

• On a quarterly basis, Receivables - Other fell 98.47% year-over-year to $769.0 in Q2 2026; TTM through Apr 2026 was $769.0, a 98.47% decrease from a year earlier, with the FY2025 full-year figure at $324318.0, up 366.95% from the prior year.
• Receivables - Other was $769.0 for Q2 2026 at Park Ha Biological Technology, up from $35.0 in the prior quarter.
• The five-year high for Receivables - Other was $69454.0 in Q4 2024, with the low at -$265755.0 in Q4 2023.
• Average Receivables - Other over 4 years is -$29023.4, with a median of $769.0 recorded in 2026.
• The sharpest annual moves came in 2024 and 2025: Receivables - Other jumped 126.13% in 2024, then slumped 99.95% in 2025.
• Over 4 years, Receivables - Other stood at -$265755.0 in 2023, then surged by 126.13% to $69454.0 in 2024, then plunged by 99.95% to $35.0 in 2025, then jumped by 2097.14% to $769.0 in 2026.
• The last three Receivables - Other figures came in at $769.0 (Q2 2026), $35.0 (Q4 2025), and $50380.0 (Q2 2025), per Business Quant data.